The purpose of this study is to perform a pragmatic randomized controlled trial to compare
the use of low molecular weight heparin (LMWH, lovenox, enoxaparin) versus acetylsalicylic
acid (ASA) for venous thromboembolism (VTE) prophylaxis in patients with high-risk lower
extremity fractures.
Phase:
Phase 3
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore